Related by context. All words. (Click for frequent words.) 67 Janus kinase 67 cell adhesion molecule 66 deoxy 66 hypoxia inducible factor 65 Upregulation 65 PDGFR 65 SSc 65 PON1 64 Polymorphisms 64 mediated apoptosis 64 HER2 HER3 64 Nedd4 64 methyltransferase 64 protein tyrosine phosphatase 1B 64 gastric carcinogenesis 64 PTPN# 64 hydroxylase 64 acyl CoA 64 Overexpression 64 sodium glucose cotransporter 64 antitrypsin 64 HER1 64 protein tyrosine phosphatase 64 FLT3 64 isoenzymes 64 diabetes mellitus T2DM 64 phosphorylated tau 64 pDC 64 interleukin IL 64 antisense inhibitor 63 Dehydrogenase 63 Enzastaurin 63 isoenzyme 63 Interferon Beta 63 Tyrosine Kinase 63 Dysregulation 63 Cytochrome 63 Genotypes 63 5 hydroxytryptamine 63 ERK signaling 63 Estrogen Receptor 63 HepDirect prodrug 63 airway hyperresponsiveness 63 5alpha reductase 63 chemokine receptor 63 Polymorphism 63 phospholipase 63 Fibroblast Growth Factor Receptor 63 Alanine 63 GSTP1 63 Secretase 63 TNFalpha 63 colony stimulating factor 63 diabetes mellitus DM 63 p# mitogen activated 62 Elevated serum 62 uricase 62 dopamine D2 62 Human Leukocyte Antigen 62 EGFR HER2 62 plasminogen activator inhibitor 62 Cytochrome P# 62 microtubule associated 62 LPS induced 62 Factor Receptor 62 metastatic neuroendocrine tumors 62 non nucleoside 62 cyclooxygenase COX 62 Phosphorylation 62 Clusterin 62 Glycosylation 62 Haptoglobin 62 Protein Kinase C 62 HMGA1 62 inducible nitric oxide synthase 62 integrin alpha 62 Cardiotoxicity 62 Tyrosine 62 proliferator activated receptor 62 Factor VIIa 62 AT1R 62 N acetyl 62 Alkaline Phosphatase 62 interleukin IL -# 62 neurofibromatosis type 62 Interferon gamma 62 Multiple Myeloma MM 62 V#F mutation 62 Signaling Pathway 62 c MET 62 Transcription Factor 62 Janus Kinase 62 diabetes dyslipidemia 62 phosphatidylinositol 3 62 Monocyte 61 Chemokine Receptor 61 COL#A# 61 peptide CGRP 61 elastase 61 metaplasia 61 mineralocorticoid 61 acyltransferase 61 ,#,# [002] 61 FGFR3 61 Oncogenic 61 regulated kinase 61 monocyte chemotactic protein 61 ABCB1 61 receptor kinase 61 FGFR1 61 TMEM#B 61 Hypercholesterolemia 61 cyclin dependent kinase 61 1 diabetes T1D 61 myeloproliferative diseases 61 Leukemias 61 von Willebrand Factor 61 Hematopoietic 61 phospholipase A2 61 monocytic 61 transferase 61 γ secretase 61 CYT# potent vascular disrupting 61 IIIb 61 CagA 61 vesicular monoamine transporter 61 Cholinesterase Inhibitors 61 MEK1 61 methylenetetrahydrofolate reductase 61 Polymerase 61 matrix metalloproteinase MMP 61 galectin 61 Autoantibodies 61 cytidine 61 triiodothyronine 61 familial amyloidotic polyneuropathy FAP 61 syntaxin 61 sitosterol 61 Myeloid 61 receptor antagonists 61 IGFBP2 61 mTOR mammalian target 60 Factor VEGF 60 selective inhibition 60 Kinase Inhibitor 60 murine model 60 HDACi 60 papillary renal cell carcinoma 60 Mutational 60 miR #a [002] 60 cyclin dependent kinase inhibitor 60 gefitinib Iressa 60 caveolin 60 LRP5 60 histological subtype 60 myelofibrosis polycythemia vera 60 iobenguane 60 HLA DR4 60 Cytoplasmic 60 anti CD3 60 PDGF receptor 60 CD# CD# 60 Cytotoxic 60 tetramer 60 Epithelial 60 circadian genes 60 irreversible inhibitor 60 nAChRs 60 histone deacetylase 60 Polyneuropathy 60 Neuroprotection 60 Eg5 60 Parathyroid Hormone 60 DNA intercalator 60 syngeneic 60 NS3 60 NIDDM 60 annexin 60 antisense oligonucleotide 60 Histone deacetylase 60 Glycoprotein 60 selective antagonists 60 pyridyl 60 Non Alcoholic Steatohepatitis 60 Ischemic 60 HDAC enzymes 60 ß1 60 Apolipoprotein 60 etiologic 60 apo AI 60 Receptor Agonist 60 interleukin IL -6 60 colorectal adenoma 60 Epitopes 60 Protease 60 UGT#A# 60 atherogenic dyslipidemia 60 humanized monoclonal 60 BMP2 60 Immunotherapeutic 60 epithelial tumors 60 essential thrombocythemia 60 tyrosine kinase receptor 60 BRAF V#E 60 Macrophage 60 capsular polysaccharide 60 heterozygotes 60 Anti Tumor 60 Phenotypic 60 Fc gamma receptor 60 Gly 60 immunoregulation 60 DNA methyltransferase 60 selective agonist 60 isoprostane 60 Inhibitory 60 perilipin 60 Angiotensin Converting Enzyme 60 mononuclear 60 glycogen synthase kinase 60 Cathepsin B 60 cystatin 60 activating mutation 60 small molecule activators 60 dehydrogenase 60 Leydig cell 60 bFGF 60 susceptibility loci 60 calcium calmodulin dependent 60 non alcoholic steatohepatitis 60 IL8 59 activin 59 Serum concentrations 59 Topoisomerase 59 thalidomide Thalomid 59 Lymphocytic 59 Beta Amyloid 59 Clinical Outcome 59 E selectin 59 #q#.# [001] 59 targeted radiotherapeutic 59 Alleles 59 diabetes hyperlipidemia 59 Tumor Necrosis Factor 59 Mimetics 59 IGFBP 59 surgically resected 59 Novel Oral 59 Alpha lipoic acid 59 glutamyl 59 Inactivation 59 DNA methyltransferases 59 missense mutations 59 Immunohistochemical analysis 59 HER2 overexpression 59 Sjögren syndrome 59 JAK2 V#F 59 IL 1ß 59 Diabetic Nephropathy 59 stem cell pluripotency 59 replicon 59 prostaglandin E 59 #p# [003] 59 Aurora Kinase 59 TIMP 1 59 Catenin 59 TNF receptor 59 Interferon beta 59 thymidine kinase 59 S#P# 59 ribosomal protein 59 glycosylation 59 metabotropic glutamate receptors 59 antiphospholipid syndrome 59 hyperparathyroidism 59 hepatic cirrhosis 59 cytochrome p# 59 TRAIL R1 59 biomarker identification 59 systemic juvenile idiopathic 59 kidney urologic 59 receptor tyrosine kinase inhibitor 59 Caveolin 1 59 vitro assay 59 Apolipoprotein E 59 gene polymorphism 59 Transmembrane 59 K ras mutations 59 1beta 59 demyelinating 59 Bosutinib 59 guanosine 59 downstream effector 59 phosphorylates 59 P#X# 59 PEGylated interferon 59 haematologic 59 herpesviruses 59 IDDM 59 PI3 59 transcriptional regulation 59 complement inhibitor eculizumab 59 potential vanilloid 59 MSH2 59 Safinamide 59 promoter polymorphism 59 transaminase 59 IL#R 59 mycosis fungoides 59 tumor xenograft models 59 glomerulonephritis 59 monogenic 59 Induces Apoptosis 59 deoxyglucose 59 Tubulin 59 T2DM 59 phospho 59 overt nephropathy 59 Monoclonal Antibody 59 Soft Tissue Sarcoma 59 TPMT 59 trans retinoic acid 59 NTx 59 Reductase 59 INS# [001] 59 Subtypes 59 glomerular 59 Hypertrophy 59 mGluR2 NAM 59 monocytes macrophages 59 IgG1 antibody 59 pan HDAC inhibitor 59 1α 59 sphingolipid 59 metalloprotease 59 carboxyl terminal 59 Squalamine 59 thymidylate synthase TS 59 erlotinib Tarceva ® 59 Naive Patients 59 MELAS 59 PEG IFN 59 Glucagon Like Peptide 58 IgG antibody 58 hypophosphatemia 58 TIMP 58 Neutrophil 58 lysosomal storage disease 58 bladder carcinoma 58 IgG4 58 diarrhea predominant irritable 58 mda 7 58 hypercalciuria 58 colorectal carcinoma 58 Immunomodulatory 58 leukocyte adhesion 58 Antigen Specific 58 atypical hemolytic uremic syndrome 58 bronchial hyperresponsiveness 58 Acetyl L Carnitine 58 Epstein Barr Virus EBV 58 glutamic acid decarboxylase 58 receptor monoclonal antibody 58 IL2 58 Fibroblast 58 genetic loci 58 2 diabetes T2D 58 tumor necrosis 58 SGPT 58 Lymphoid 58 N acetylgalactosamine 58 transcranial Doppler ultrasound 58 Transgenic Mice 58 adipogenesis 58 tryptase 58 metabolizing enzyme 58 Initiated Phase 58 chromosomal mutations 58 gastric adenocarcinoma 58 Hypertriglyceridemia 58 TGR5 58 fluconazole resistant 58 eIF 4E 58 NQO1 58 ACC2 58 FGFR 58 ERBB2 58 pancreatic prostate 58 Lymphocyte 58 NY ESO 58 therapeutic monoclonal antibody 58 histone deacetylase HDAC 58 Epidermal Growth Factor Receptor 58 GW# [003] 58 Herpes Simplex 58 fasting plasma 58 retinoic acid receptor 58 hepatocellular carcinomas 58 R Saizen R 58 Glioma 58 siRNAs targeting 58 inosine 58 upregulating 58 Antitumor 58 selective adenosine 58 immuno modulatory 58 clade B 58 neuropathic pain metabolic diseases 58 IgA deficiency 58 Mutagenesis 58 Secretory 58 Interferon alfa 58 MLH1 58 Peginterferon Alfa 2a 58 urothelial carcinoma 58 myeloperoxidase 58 Subtype 58 synaptic vesicle 58 abacavir Ziagen 58 mediated inhibition 58 Supplemental Figure 58 Antiviral Therapy 58 apoE 58 ERK1 2 58 p tau 58 Non Responders 58 metastatic malignant 58 SCD1 58 COX2 58 astrocytomas 58 adrenoceptor 58 alpha1 58 methoxy 58 ABL1 58 TNF Tumor Necrosis Factor 58 ara C 58 Adenoviral 58 Cystatin C 58 Tyrosine Kinase Inhibitor 58 Immunohistochemical staining 58 tenascin 58 apolipoprotein B 58 prostate carcinoma 58 Quantitation 58 potently inhibit 58 miR #a [001] 58 glycopeptide 58 haptoglobin 58 Cytomegalovirus CMV 58 Targeted Therapy 58 Huntingtin 58 Cardiac Troponin 58 vacuolar 58 severe NCI Grades 58 immunostaining 58 subtype selective 58 Anaplastic 58 Papillary 58 germline mutations 58 susceptibility gene 58 aspartate aminotransferase 58 Shows Promise Against 58 Dasatinib 58 IgA antibodies 58 aminopeptidase 58 TGF β 58 phosphatidylinositol 58 proline residues 58 humanised antibody 58 lymphoproliferative disorders 58 MKC# MT 58 GSTT1 58 receptor partial agonist 58 selective antagonist 58 T#I [002] 58 extracellular signal 58 ESCRT 58 acetylcholinesterase AChE 58 Synthase 58 PAOD 58 fosbretabulin 58 renal fibrosis 57 serum cortisol 57 Synuclein 57 null mice 57 siRNA therapeutic 57 beta lactamase inhibitor 57 poly ADP ribose polymerase 57 dasatinib Sprycel 57 HLA DRB1 * 57 phenothiazines 57 Squamous 57 Survivin 57 Chronic HCV 57 HLA DQ2 57 quinone 57 SGOT 57 transgenic mouse models 57 chromosomal rearrangement 57 dorsal root ganglion 57 Microtubule 57 gastrin analogue TT 57 bronchoalveolar lavage 57 ductal adenocarcinoma 57 hydroxyproline 57 lactate dehydrogenase LDH 57 missense mutation 57 NKX2 57 Figure S4 57 rxRNA 57 Incretin 57 Retreatment 57 F FLT 57 Growth Hormone Deficiency 57 Immune Responses 57 glucosylceramide 57 RRM1 57 beta. 57 defensin 57 Histopathologic 57 microsatellite instability 57 Tumor Suppressor 57 T#M 57 mitochondrial toxicity 57 Signaling Pathways 57 diabetic microvascular complications 57 lymphoma subtypes 57 imatinib resistance 57 therapeutically relevant 57 tuberous sclerosis TS 57 Initiate Clinical Trial 57 MYH9 gene 57 glutamate transporter 57 NMDA antagonists 57 dependent protein kinase 57 beta tubulin 57 gastric carcinoma 57 liver histology 57 Herpes simplex virus 57 transgenic mouse model 57 pairwise comparisons 57 receptor IGF1R 57 Hypothalamic 57 Epstein Barr Virus 57 Genotype 57 scavenger receptor 57 prostate cancer PCa 57 TRAF1 57 CDH1 57 beta3 57 Pharmacokinetics PK 57 TGF ß 57 Diabetic neuropathy 57 MAP kinase 57 breast carcinomas 57 Fig. 1E 57 Prostatic 57 neovascularisation 57 benign neoplasms 57 protein tyrosine phosphatases 57 alanine aminotransferase ALT 57 Atopic 57 cationic lipid 57 EP4 57 Alzheimer Disease AD 57 mutated K ras 57 NOD mouse 57 methyl CpG binding 57 Ribosomal 57 elevated triglyceride levels 57 plasma lipids 57 bone morphogenic protein 57 Diabetic Neuropathy 57 Thiamine 57 JAK STAT 57 lymphoid cells 57 intact parathyroid hormone 57 Azacitidine 57 euthymic patients 57 Prospective Randomized 57 cefotaxime 57 Galectin 3 57 Nilotinib 57 Oral Fingolimod 57 procollagen 57 macroalbuminuria 57 small molecule activator 57 delta gamma agonist 57 NTDDS 57 myeloproliferative 57 peptidase 57 cytokines IL 57 myotonic muscular dystrophy 57 parthenolide 57 tissue fibrosis 57 modifier genes 57 Myelodysplastic Syndrome MDS 57 VLDL cholesterol 57 cytochrome 57 chromosome #q#.# [001] 57 including eniluracil ADH 57 demethylase 57 Fibrosis 57 Allogeneic 57 hypothalamic pituitary 57 triglycerides TG 57 Fludarabine 57 genetic variants associated 57 HIF 1α 57 pulmonary hypertension PH 57 carbonyls 57 galectins 57 Protein Interactions 57 alpha1 proteinase inhibitor 57 colesevelam HCl 57 TRAIL R2 57 eccrine 57 #β estradiol 57 cervical intraepithelial neoplasia 57 azacytidine 57 cytotoxin 57 immunodeficiencies 57 Fabry Disease 57 Atopic Dermatitis 57 IAP inhibitor 57 Systemic Juvenile Idiopathic 57 constipation predominant IBS 57 glutathione S transferase 57 Systemic Delivery 57 follicular lymphoma FL 57 Mg Usa 57 serum homocysteine 57 apolipoprotein E 57 Epithelial Cell 57 Deficient Mice 57 Omacetaxine 57 systemic amyloidosis 57 Muscarinic 57 Advanced Renal Cell 57 prognostic biomarker 57 Monoclonal antibody 57 Monoclonal 56 NS#/#A protease 56 pulmonary metastasis 56 Novel Inhibitor 56 Atherosclerotic 56 Neurofibromatosis Type 56 SOD1 56 PC# cells 56 hyperlipidemic 56 Prodarsan R 56 Mutation Analysis 56 neuroligin 56 homolog 56 Transcriptional 56 myeloproliferative neoplasms 56 chronic eosinophilic leukemia 56 Genetic Variation 56 basal cell nevus syndrome 56 Leukotriene 56 Tocopherol 56 PEGylated anti 56 CLL SLL 56 esophageal carcinoma 56 decarboxylase 56 grade cervical intraepithelial 56 pharmacodynamic PD 56 intercellular signaling 56 lymphocytic 56 radioimmunoassay 56 ALN HPN 56 T1DM 56 phosphodiesterase PDE 56 microdeletions 56 constitutively expressed 56 glucose insulin 56 keratinocyte 56 PLA2 56 PI3K AKT 56 immunoglobulin G 56 p# biomarker 56 Multidrug Resistance 56 histologic subtype 56 lung fibrosis 56 hematological parameters 56 PsA 56 malondialdehyde 56 Binding Protein 56 PAR1 56 paraneoplastic 56 subependymal giant cell 56 Cell Lymphoma 56 MTHFR gene 56 SERCA2a 56 neurite outgrowth 56 coagulation cascade 56 Deforolimus 56 osteosarcomas 56 onset diabetes mellitus 56 functional polymorphism 56 sodium thiosulfate STS 56 NAGS deficiency 56 bisoprolol 56 succinate dehydrogenase 56 insulin resistance syndrome 56 edifoligide 56 somatostatin analogs 56 Fibrinogen 56 Lipoprotein 56 Progenitor Cells 56 antisense oligonucleotides 56 MT1 MMP 56 tumor hypoxia 56 hypereosinophilic syndrome 56 Potent Anti 56 Methionine 56 transient receptor 56 Micromet BiTE 56 Hepatocellular 56 Interleukin IL 56 Entamoeba histolytica 56 Prostaglandin 56 Cutaneous T 56 fibrotic disease 56 r2 = 56 neurological manifestations 56 PPAR gamma agonist 56 Hepatic Encephalopathy 56 esophageal squamous cell carcinoma 56 vascular disrupting agents 56 molecular abnormalities 56 mol L 56 HuMax EGFr 56 PPARγ 56 Microalbuminuria 56 Meets Primary Endpoint 56 Leucovorin 56 RNAi therapeutic targeting 56 missense 56 Protease Inhibitor 56 Hemophilia B 56 IFNs 56 intraepithelial neoplasia 56 neutropaenia 56 Demonstrated Significant 56 Nucleoside 56 protein biosynthesis 56 Inflammatory Markers 56 conventional DMARDs 56 Chronic lymphocytic leukemia 56 lysosomal storage diseases 56 epigenetic therapies 56 insulin glulisine 56 serum leptin 56 glycated 56 Non Insulin Dependent 56 squamous 56 NPM1 56 intercellular adhesion molecule 56 erosive gastritis 56 Insulin detemir 56 Aurora kinase 56 intraabdominal 56 tumor suppressor protein 56 distinct subtypes 56 Tumor Response 56 gp# protein [002] 56 Preclinical Study 56 Glucocorticoids 56 thyrotropin 56 lung carcinomas 56 ARRY # 56 fibrosing 56 Kinase Inhibitors 56 nephropathy 56 erythematosus 56 Heterogeneity 56 ataxias 56 Arrhythmogenic 56 Genetic variation 56 Mouse Model 56 Wnt signaling pathway 56 #p#.# [002] 56 FDG PET imaging 56 intraepithelial 56 C#Y 56 sporadic ALS 56 phosphate dehydrogenase 56 HLA B# 56 Transcriptome 56 adrenergic receptor 56 MTHFR 56 ADPKD 56 Erythropoietic 56 PSMA ADC 56 Eur J Endocrinol 56 neovascular 56 C Reactive Protein 56 receptors PPARs 56 Stromal 56 JAK3 56 neuroendocrine cancers 56 radiolabeled antibodies 56 idiopathic PAH 56 Supplementary Table 56 apolipoproteins 56 Haplotype 56 airway hyper responsiveness 56 Enzyme Replacement Therapy 56 Bosentan 56 GlcNAc 56 atherogenesis 56 Spiegelmer 56 arginine vasopressin AVP 56 Morphological 56 ocular disorders 56 vWD 56 CIAS1 56 agonist antagonist 56 heterozygous familial 56 benzothiazole 56 progressive neurodegenerative disorder 56 hormone LHRH 56 Clinical Relevance 56 Antitumor Activity 56 Acidosis 56 methicillin susceptible Staphylococcus aureus 56 Hyperlipidemia 56 Neurogenic 56 thymidine 56 JAK1 56 JAK2 gene 55 pulmonary metastases 55 delta isoform 55 Chronic Prostatitis 55 ANCA associated 55 muscle contractility 55 hematopoiesis 55 serum phosphate 55 MGUS 55 bronchoalveolar lavage fluid 55 NSCLC tumors 55 lysosomal enzyme iduronate 55 homozygote 55 Malignancies 55 Cytotoxic T 55 CC genotype 55 Protease Inhibitors 55 Chemotherapy Induced 55 basal cell carcinoma BCC 55 cystic fibrosis chronic pancreatitis 55 NRF2 gene 55 costimulatory 55 CD#L 55 Xanafide 55 ^ sup #m 55 Innate Immune 55 underlying vasculopathy 55 essential thrombocythemia ET 55 leukemia AML 55 Rearrangements 55 Bioavailability 55 molecular biomarkers 55 systemic lupus erythematosus 55 mGluR 55 triglyceride concentrations 55 Malignant Melanoma 55 Cerebellar 55 Androgen Receptor 55 anorexia cachexia 55 lyase 55 differential gene expression 55 Allergic Rhinitis 55 HBeAg negative 55 susceptibility alleles 55 metabolomic profiles 55 polyarticular 55 primary hyperparathyroidism 55 dinucleotide 55 lipid abnormalities 55 Extracellular 55 Adenovirus 55 urothelial cancer 55 Systemic Lupus Erythematosus SLE 55 Pegylated Interferon 55 Respiratory Virus 55 Hedgehog signaling 55 hydroxylation 55 p# antigen 55 Relapsed Refractory 55 Phenotypes 55 Mycophenolate Mofetil 55 histologically proven 55 tumorigenicity 55 Epratuzumab 55 Initiate Phase 55 apo E 55 generalized epilepsy 55 HT 2A 55 glycated hemoglobin levels 55 serine 55 MYCN amplification 55 ApoE 55 prucalopride 55 neuropilin 55 papillary RCC 55 creatine kinase CK 55 nonalcoholic steatohepatitis 55 Symadex 55 non coding RNA 55 pulmonary arterial 55 Artificial Pancreas 55 bleomycin 55 Critical Limb Ischemia CLI 55 CDK5 55 plasma pharmacokinetics 55 IIb 55 hypercholesterolaemia 55 Orally Active 55 hyperinsulinemia 55 metastatic lymph nodes 55 adult mesenchymal stem 55 Mol Cell 55 CIN2 + 55 Juvenile Idiopathic Arthritis 55 SPRYCEL ® 55 amino acid metabolism 55 anticancer therapeutics 55 pheochromocytoma 55 rs# [002] 55 antibody mediated 55 carboxy terminal 55 Small Molecule 55 retroviral vectors 55 B Cell Lymphoma 55 chemokine receptors 55 LSD1 55 alpha1 antitrypsin deficiency 55 Caveolin 55 Phase 2b Trial 55 vinca alkaloid 55 Gene Mutation 55 Metastases 55 J Allergy Clin 55 glycogen storage 55 55 multicentric 55 aberrantly activated 55 DAS# CRP 55 cinacalcet 55 thiazolidinediones TZDs 55 triglyceride TG 55 erythroid 55 See CLINICAL PHARMACOLOGY 55 immunotoxins 55 QTL mapping 55 uM 55 preclinical efficacy 55 Novel Compound 55 Respiratory Syncytial Virus RSV 55 pioglitazone HCl 55 beta 1a 55 dual PPAR peroxisome 55 Mucopolysaccharidosis 55 hepatic glucose production 55 Neovascularization 55 monoclonal antibody conjugated 55 Complicated Skin 55 Replacement Therapy 55 mitotic kinesin 55 Epitope 55 hnRNP 55 dynamin 55 IGF binding 55 eNOS 55 flavopiridol 55 dyslipidaemia 55 Decitabine 55 ligases 55 refractory anemia RA 55 phosphorylase 55 Parainfluenza 55 synthetic peptides 55 airway hydration 55 osteoblast differentiation 55 hyperplastic 55 tiuxetan 55 cerebral vasospasm 55 MEF2A 55 protein secreted 55 oral antidiabetic drugs 55 Gamma secretase 55 cyclic adenosine monophosphate cAMP 55 Novel Therapeutic 55 Phosphodiesterase 55 impaired glucose metabolism 55 hypomethylation 55 targeting miR 55 gene loci